Download PDF
1 / Pages

Other users also viewed these articles

P-111 FREQUENCY OF LIVER STEATOSIS AND FIBROSIS DETERMINED BY FIBROSCAN AND CAP IN A SCREENING PROGRAM Pedro Montes Teves; Rocío Galloso Gentille; Diego Rosales Ruiz; Flor Beltran Valdivia; Claudia Mori Torres; Vanessa Valenzuela Granados; Flor Araujo León; Cecilia Cabrera Cabrejos; Bertha Cárdenas Ramírez; Jaime Fustamante Flores; Roxana Gallegos López; Carlos García-Encinas; Carlos Nureña Flores; Rossana Ráez León; Rocío Ramos Miraval; Briny Rodríguez Vargas; Julio Santiago Marcelo; Stefanie Salazar Rivas; Sonia Salazar Ventura; María Grazia Venturelli Romero;
Ann Hepatol. 2021;24 Supl 1:
P-73 NORADRENALINE IN THE TREATMENT OF HEPATORENAL SYNDROME TYPE AKI: RESULTS IN NON-ICU HOSPITAL SETTING Zuly Plácido Damián; Javier Diaz Ferrer; Giancarlo Perez Lazo;
Ann Hepatol. 2024;29 Supl 3:
Assessment of TLL1 variant and risk of hepatocellular carcinoma in Latin Americans and Europeans Siyu Fu; Dhamina Karim; Jhon Prieto; Domingo Balderramo; Javier Diaz Ferrer; Angelo Z. Mattos; Marco Arrese; Enrique Carrera; Jeffrey Oliveira; Jose D. Debes; Andre Boonstra;
Ann Hepatol. 2024;29: